Daily consumption of unsalted, skin-roasted peanuts was associated with improved insulin responsiveness in several memory-related brain regions in older adults, according to research from Maastricht University Medical Center.
The study, published in Food & Function, examined the effects of a 16-week peanut-consumption period on the brain’s response to insulin. Researchers reported a beneficial change in a cluster in the right hemisphere that included parts of the hippocampus, parahippocampal gyrus, lingual gyrus and posterior cingulate gyrus.
Why brain insulin response matters
Insulin is widely known for its role in regulating blood sugar, but it also acts as a signaling molecule in the brain. It supports nerve-cell survival, growth and communication, processes that are important for memory and other cognitive functions.
As people age, the brain can become less responsive to insulin. That reduced responsiveness has been linked to age-related cognitive decline. The new findings therefore focus on a biological signal that may be relevant to brain health, rather than on a direct measure of whether peanuts prevent cognitive disease.
“The hormone insulin plays an important role in the brain, where it supports memory and other cognitive processes,” Peter Joris, the study’s senior author and an associate professor at Maastricht University Medical Center, said in a statement. The researchers said their results suggest that enhanced regional responsiveness could contribute to cognitive benefits associated with peanut intake.
Changes appeared in memory-related regions
The study measured insulin-induced changes in regional cerebral blood flow after intranasal insulin. In a whole-brain analysis, the researchers identified one cluster where the response was beneficially affected after the peanut intervention compared with the control period.
That cluster included the hippocampus and parahippocampal gyrus, regions commonly associated with memory, alongside the lingual gyrus, thalamus and posterior cingulate gyrus. The reported change was regional rather than a finding that every part of the brain responded differently.
This distinction is important. The research does not establish that eating peanuts treats Alzheimer’s disease, reverses cognitive decline or guarantees improved memory. It reports a change in a physiological response to insulin in specific brain areas after a defined dietary intervention.
A food-based intervention, with limits
Food studies can offer useful clues because they examine interventions that are practical to incorporate into daily life. But findings of this kind need to be interpreted in the context of the study’s population, duration and outcome measures.
Here, the intervention lasted 16 weeks and involved older adults consuming unsalted, skin-roasted peanuts. The source material does not support extending the finding to every age group, every peanut preparation or every cognitive outcome. It also does not show that peanuts should replace clinical care or broader dietary guidance.
The study nevertheless adds to interest in how dietary patterns and individual foods may affect the brain through metabolic pathways. Rather than treating insulin solely as a hormone relevant to the pancreas and circulation, the work highlights its signaling role in the central nervous system.
For readers considering the result, the clearest takeaway is narrow: in this study, longer-term daily consumption of a specific peanut preparation was associated with a more favorable brain response to insulin in a set of regions involved in memory. Further work would be needed to determine how durable that effect is and whether it translates into measurable changes in cognition.
What comes next
Research on nutrition and brain health often advances through such intermediate measures. Physiological signals can help scientists identify plausible mechanisms before larger studies test clinical outcomes over longer periods.
The Maastricht findings point to brain insulin responsiveness as one mechanism worth following. They also underscore why dietary claims should be calibrated to the evidence: a promising change in a biomarker or imaging-related measure is not the same as proof of disease prevention.
For now, the study provides evidence that a commonly available food can affect an insulin-related brain response in older adults under the conditions tested. Its most significant contribution may be the question it raises for future research: whether improving insulin responsiveness in memory-related brain regions can ultimately support healthier cognitive aging.
This article is based on reporting by Medical Xpress. Read the original article.
Originally published on medicalxpress.com
